Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumor

Explore clinical trials studying Advanced Solid Tumor. Study availability and eligibility vary by location and protocol.

514 public trials 240 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumor trial results

Recruiting

A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors

NCT06625593

Conditions
Advanced Solid Tumor
Locations
  • Usc Norris Comprehensive Cancer Center (Nccc) Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • Md Anderson Cancer Center Houston, Texas, United States
View all 52 locations
View Trial Details
Recruiting

Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors

NCT06233942

Conditions
Advanced Solid Tumor
Locations
  • Usc Norris Comprehensive Cancer Center (Nccc) Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Florida Cancer Specialist Research Institute Lake Nona Orlando, Florida, United States
  • Sidney Kimmel Comprehensive Cancer At Johns Hopkins Baltimore, Maryland, United States
View all 37 locations
View Trial Details
Recruiting

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

NCT06803680

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • Adventhealth Celebration, Florida, United States
  • Sidney Kimmel Cancer Center Philadelphia, Pennsylvania, United States
  • Avera Cancer Institute Sioux Falls, South Dakota, United States
  • Next Oncology San Antonio, Texas, United States
View all 13 locations
View Trial Details
Recruiting

A Study of PYX-201 in Advanced Solid Tumors

NCT05720117

Conditions
Advanced Solid Tumor, Neoplasm Metastasis, Neoplasms, +4 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • SCRI - HealthOne Denver Denver, Colorado, United States
  • SCRI - Florida Cancer Specialists Sarasota, Florida, United States
View all 29 locations
View Trial Details
Recruiting

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

NCT05170958

Conditions
Advanced Solid Tumor
Locations
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Anhui Provincial Hospital Hefei, Anhui, China
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 49 locations
View Trial Details
Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

NCT04585750

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Solid Tumor, +81 more
Locations
  • University of California Irvine Chao Family Comprehensive Cancer Center Irvine, California, United States
  • University of San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 77 locations
View Trial Details
Recruiting

SNV1521 in Participants With Advanced Solid Tumors

NCT06220864

Conditions
Advanced Solid Tumor
Locations
  • Smilow Cancer Hospital at Yale New Haven New Haven, Connecticut, United States
  • Thomas Jefferson University Philadelphia, Pennsylvania, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
View all 25 locations
View Trial Details
Recruiting

Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors

NCT06352359

Conditions
Advanced Solid Tumor
Locations
  • University of California at Davis Cancer Center Sacramento, California, United States
  • UF Health Cancer Center, University of Florida Gainesville, Florida, United States
  • AdventHealth Medical Group Oncology Research at Celebration Kissimmee, Florida, United States
  • Norton Cancer Center Louisville, Kentucky, United States
View Trial Details
Recruiting

A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

NCT06952010

Conditions
Advanced Solid Tumor, Immune Sensitive Tumor, Metastatic Solid Tumor, +6 more
Locations
  • Exelixis Clinical Site #5 San Francisco, California, United States
  • Exelixis Clinical Site #4 New Haven, Connecticut, United States
  • Exelixis Clinical Site #8 Tampa, Florida, United States
  • Exelixis Clinical Site #10 Boston, Massachusetts, United States
View Trial Details

Related conditions